|
|
Volumn 3, Issue 6, 2007, Pages 326-329
|
|
American Society of Clinical Oncology 2007 clinical practice guideline recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
a a a a a a a a a a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIVITAMIN K;
COUMARIN;
DEXAMETHASONE;
FONDAPARINUX;
HEPARIN;
LENALIDOMIDE;
LOW MOLECULAR WEIGHT HEPARIN;
PLACEBO;
THALIDOMIDE;
WARFARIN;
ANTICOAGULATION;
ARTICLE;
BLEEDING;
BLOOD CLOT LYSIS;
BLOOD CLOTTING DISORDER;
BRAIN HEMORRHAGE;
BRAIN METASTASIS;
BRAIN SURGERY;
BRAIN TUMOR;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
COMPRESSION THERAPY;
COST CONTROL;
DISEASE ASSOCIATION;
DRUG CONTRAINDICATION;
DRUG DOSE COMPARISON;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EVIDENCE BASED MEDICINE;
HEPARIN INDUCED THROMBOCYTOPENIA;
HIGH RISK PATIENT;
HOSPITAL PATIENT;
HUMAN;
INCIDENCE;
INTERNATIONAL NORMALIZED RATIO;
LONG TERM CARE;
LUNG SMALL CELL CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL SOCIETY;
MONOTHERAPY;
MULTIPLE MYELOMA;
OSTEOPOROSIS;
OUTPATIENT;
PATIENT IDENTIFICATION;
PATIENT SAFETY;
PATIENT SELECTION;
POSTOPERATIVE THROMBOSIS;
PRACTICE GUIDELINE;
PROTECTIVE CLOTHING;
RECOMMENDED DRUG DOSE;
RECURRENT DISEASE;
RISK FACTOR;
RISK REDUCTION;
SYSTEMIC THERAPY;
THROMBOCYTOPENIA;
THROMBOSIS PREVENTION;
TREATMENT FAILURE;
VENA CAVA FILTER;
VENOUS THROMBOEMBOLISM;
|
|
EID: 42549133080
PISSN: 15547477
EISSN: None
Source Type: Journal
DOI: 10.1200/JOP.0768502 Document Type: Article |
|
Times cited : (7)
|
|
References (1)
|
